Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

18 Feb 2020

Upcoming event: CEPI and IABS co-host March meeting to discuss licensure of vaccine platform technologies
The two-day event with International Alliance for Biological Standardization (IABS) takes place from Monday 16 March to Tuesday 17 March  in Brussels, Belgium. Registration is now open.

Read more

Read article

17 Feb 2020

Norway provides NOK 36 million additional funding to CEPI in response to COVID-19
The increased investment will support CEPI’s COVID-19 vaccine programmes which aim to advance candidates into clinical testing as quickly as possible.

Read more

10 Feb 2020

Ethiopia funds Coalition for Epidemic Preparedness Innovations to combat spread of epidemics
Ethiopia pledges USD$300,000 to support CEPI’s mission to accelerate development of vaccines against emerging infectious diseases

Read more

03 Feb 2020

CEPI launches new call for proposals to develop vaccines against novel coronavirus, 2019-nCoV
The rolling call was open for two weeks and aims to complement CEPI’s newly developed 2019-nCoV portfolio. All organisations worldwide were invited to apply.

Read more

03 Feb 2020

UK Government supports CEPI with £20 million additional funding
The UK Government’s Department of Health and Social Care has announced an additional £20 million funding to CEPI to further our mission to advance vaccines against epidemic threats.

Read more

03 Feb 2020

CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
GSK to make adjuvant technology available to support rapid development of candidate vaccines.

Read more

31 Jan 2020

CureVac and CEPI extend their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019
CEPI funds CureVac’s development of a vaccine against coronavirus nCoV-2019. The aim of the partnering agreement is to rapidly advance a vaccine candidate into clinical testing.

Read more

23 Jan 2020

CEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-2019
The programmes will leverage rapid response platforms already supported by CEPI as well as a new partnership. The aim is to advance nCoV-2019 vaccine candidates into clinical testing as quickly as possible.

Read more

Read article

17 Jan 2020

Newly discovered coronavirus in Wuhan China
Our CEO, Richard Hatchett, discusses how the rapid publication of the genetic sequence of the newly discovered beta coronavirus could help speed up the development of diagnostic tests, case detection, and, potentially, a vaccine.

Read more

15 Jan 2020

[email protected]: The threat of a Nipah epidemic has not gone away
In 1999, an outbreak of a previously unknown virus caused over 100 deaths in Malaysia and Singapore. In an article in The Straits Times, CEPI's CEO, Richard Hatchett, explores the history of previous Nipah outbreaks and the future threat of the emerging infectious disease.

Read more

09 Dec 2019

[email protected]: New conference to explore innovative solutions to combat global health threat posed by Nipah virus
The Nipah Virus International Conference 2019—co-hosted by Duke-NUS Medical School (Duke-NUS) and the Coalition for Epidemic Preparedness Innovations (CEPI)—brings together world’s leading Nipah experts to strengthen international collaboration and improve world’s ability to combat the deadly virus.

Read more

©2020 CEPI. All rights reserved

This website uses cookies to improve functionality and performance. If you continue browsing the site, you consent to the use of cookies on this website. For details, see our Cookie Notice.